YPSN.SW
Healthcare Medical Instruments & SuppliesYpsomed Holding AG
CHF 358.00
-1.60 -0.44% today
Price History
Not enough data
Key Stats
Market Cap
4.71B
Avg Volume
14,694
P/E (TTM)
21.96
EPS
CHF 16.30
52W High
CHF 418.00
52W Low
CHF 260.50
Div. Yield
1.2%
Analyst Ratings
Buy3
Str Buy
5
Buy
4
Hold
1
Sell
0
Str Sell
Valuation
Forward P/E
24.32
P/B Ratio
6.29
P/S Ratio
6.44
EV/EBITDA
15.16
EV/Revenue
6.76
PEG Ratio
3.21
Margins
Gross Margin 43.0%
Operating Margin 26.5%
Net Margin 30.4%
EBITDA Margin 44.6%
Growth & Returns
Revenue Growth (YoY)
(13.3%)
Earnings Growth (YoY)
51.7%
Earnings Growth (QoQ)
50.9%
Return on Equity
31.1%
Return on Assets
12.4%
Liquidity & Leverage
Current Ratio
1.07
Quick Ratio
0.73
Debt / Equity
0.35
Total Cash
28.56M
Total Debt
260.77M
About
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally. The company offers various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other related services. It offers contract manufacturing of infusion sets and reservoirs. The company markets its products to hospitals, doctors, pharmacies and patients via subsidiaries and distributors. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
www.ypsomed.com